Showing results (11-20 of 276) with videos related to
Sort By:
Pageof 28
Developmental Biology|August 25, 1996
Early embryonic lethality caused by targeted disruption of the mouse thioredoxin geneM Matsui, M Oshima, H Oshima, et al.Molecular Carcinogenesis|January 1, 1996
Effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on intestinal polyp development in Apc delta 716 knockout miceM Oshima, H Oshima, M Tsutsumi, et al.Genes to Cells : Devoted to Molecular & Cellular Mechanisms|May 21, 1999
Impaired extrapyramidal function caused by the targeted disruption of retinoid X receptor RXRgamma1 isoformY Saga, M Kobayashi, H Ohta, et al.The EMBO Journal|November 2, 1999
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin geneN Harada, Y Tamai, T Ishikawa, et al.Nature Medicine|September 5, 2001
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout miceM Sonoshita, K Takaku, N Sasaki, et al.Endocrine|February 2, 2002
Morphologic and molecular analysis of estrogen-induced pituitary tumorigenesis in targeted disruption of transforming growth factor-beta receptor type II and/or p27 miceH Ikeda, T Yoshimoto, N Shida, et al.International Journal of Oncology|September 20, 2002
CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: Prognostic implicationsH Seno, M Oshima, M-A Taniguchi, et al.Journal of the National Cancer Institute|November 12, 1998
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)M M TaketoInflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 27, 1998
COX-2 and colon cancerM M TaketoJournal of the National Cancer Institute|October 28, 1998
Cyclooxygenase-2 inhibitors in tumorigenesis (part I)M M TaketoPageof 28